|
|
Volumn 104, Issue 4, 2011, Pages 279-280
|
|
Bisphosphonates and osteoporosis: Which therapeutic agent is best?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
IBANDRONIC ACID;
LIPID;
PHYTOSTEROL;
RISEDRONIC ACID;
ZOLEDRONIC ACID;
ARTHRALGIA;
CARDIOVASCULAR DISEASE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL PRACTICE;
DIGESTIVE SYSTEM INFLAMMATION;
DRUG SAFETY;
DYSLIPIDEMIA;
EDITORIAL;
EVIDENCE BASED MEDICINE;
FRACTURE;
FRUIT;
HEART ATRIUM FIBRILLATION;
HUMAN;
JAW OSTEONECROSIS;
LEGUME;
MALAISE;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
NUT;
OSTEOPOROSIS;
PRIORITY JOURNAL;
|
|
EID: 79953777180
PISSN: 14602725
EISSN: 14602393
Source Type: Journal
DOI: 10.1093/qjmed/hcr047 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
